Response to Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247-1251.
Joseph H TaubeSalvatore FrulloneMaria MorganteGaetano MacinaAntonella PansiniJessica GambardellaAngela LombardiPasquale MonePublished in: Diabetes care (2022)